Enzymes — MCQs

Enzymes Indian Medical PG Practice Questions and MCQs

Question 411: Which of the following is NOT a mixed-function oxidase?

A. Homogentisate oxidase (Correct Answer)
B. Cytochrome P-450
C. Phenylalanine hydroxylase
D. Tryptophan hydroxylase

Explanation: ### Explanation The key to answering this question lies in distinguishing between **Dioxygenases** and **Monooxygenases (Mixed-Function Oxidases)**. **1. Why Homogentisate Oxidase is the Correct Answer:** Homogentisate oxidase is a **dioxygenase**. In biochemical reactions, dioxygenases incorporate **both atoms** of molecular oxygen ($O_2$) directly into the substrate. In the phenylalanine/tyrosine catabolic pathway, homogentisate oxidase catalyzes the conversion of homogentisate to maleylacetoacetate by incorporating two oxygen atoms. Because it does not require a co-substrate to "accept" the second oxygen atom, it is not a mixed-function oxidase. **2. Why the Other Options are Incorrect:** Options B, C, and D are all **Mixed-Function Oxidases (Monooxygenases)**. These enzymes incorporate only **one atom** of $O_2$ into the substrate (as a hydroxyl group), while the other oxygen atom is reduced to **water ($H_2O$)**. This process requires a second substrate (electron donor) like NADPH or Tetrahydrobiopterin ($BH_4$). * **Cytochrome P-450:** The classic example of a monooxygenase used in drug metabolism and steroid synthesis. * **Phenylalanine Hydroxylase:** Converts Phenylalanine to Tyrosine using $BH_4$ as a co-reductant. * **Tryptophan Hydroxylase:** Converts Tryptophan to 5-Hydroxytryptophan (serotonin precursor) using $BH_4$. **Clinical Pearls for NEET-PG:** * **Alkaptonuria:** Deficiency of **Homogentisate oxidase** leads to the triad of dark urine (on standing), ochronosis (pigmentation of connective tissue), and arthritis. * **Phenylketonuria (PKU):** Deficiency of **Phenylalanine hydroxylase** is the most common cause. * **Cofactor Alert:** Most hydroxylases (Mixed-function oxidases) in amino acid metabolism require **Tetrahydrobiopterin ($BH_4$)** as a cofactor.

Question 412: What is the number of isoenzymes of Lactate Dehydrogenase (LDH)?

A. 1
B. 3
C. 4
D. 5 (Correct Answer)

Explanation: **Explanation:** Lactate Dehydrogenase (LDH) is a tetrameric enzyme (composed of four subunits) that catalyzes the reversible conversion of lactate to pyruvate. The correct answer is **5** because LDH is formed by the combination of two distinct polypeptide chains: **H (Heart)** and **M (Muscle)**. Since the enzyme is a tetramer, these two subunits can combine in five different permutations, resulting in five distinct isoenzymes: * **LDH-1 (H4):** Predominantly in the heart and RBCs. * **LDH-2 (H3M1):** Predominantly in the Reticuloendothelial system. * **LDH-3 (H2M2):** Predominantly in the lungs. * **LDH-4 (H1M3):** Predominantly in the kidneys and pancreas. * **LDH-5 (M4):** Predominantly in the liver and skeletal muscle. **Analysis of Incorrect Options:** * **Option A (1):** Incorrect. Enzymes with multiple subunits and tissue-specific expressions usually exist in multiple isoforms. * **Option B (3):** Incorrect. This might be confused with Creatine Kinase (CK), which has 3 isoenzymes (CK-MM, CK-MB, CK-BB). * **Option C (4):** Incorrect. While LDH is a tetramer (4 subunits), the mathematical combinations of two different subunits (H and M) result in five possible arrangements. **High-Yield Clinical Pearls for NEET-PG:** * **Flipped Pattern:** Normally, LDH-2 > LDH-1. In **Myocardial Infarction (MI)** or hemolytic anemia, LDH-1 levels exceed LDH-2 (LDH-1/LDH-2 ratio >1), known as the "flipped pattern." * **LDH-5:** Is the most heat-labile isoenzyme and serves as a marker for liver cell damage or skeletal muscle injury. * **Total LDH:** Is a non-specific marker of cellular turnover; significantly elevated levels are seen in megaloblastic anemia and certain malignancies (e.g., Seminoma, Lymphoma).

Question 413: All of the following are serine proteases, except?

A. Chymotrypsin
B. Trypsin
C. Thrombin
D. Carboxypeptidase (Correct Answer)

Explanation: **Explanation:** The classification of proteases is based on the functional group present at their active site that initiates the peptide bond cleavage. **1. Why Carboxypeptidase is the correct answer:** Carboxypeptidase is a **Zinc-containing Metalloenzyme** (specifically a metalloprotease). It requires a metal ion (Zn²⁺) to activate a water molecule, which then attacks the peptide bond. Unlike serine proteases, it does not utilize a serine residue for its catalytic mechanism. It is an exopeptidase that cleaves amino acids from the C-terminal end of proteins. **2. Why the other options are incorrect:** * **Chymotrypsin & Trypsin:** These are classic examples of pancreatic serine proteases. They utilize a "Catalytic Triad" consisting of **Serine, Histidine, and Aspartate**. The serine residue acts as a nucleophile to attack the carbonyl carbon of the substrate. * **Thrombin:** This is a critical serine protease in the coagulation cascade. It converts fibrinogen to fibrin. Like trypsin, it cleaves peptide bonds following specific basic amino acid residues. **3. High-Yield Clinical Pearls for NEET-PG:** * **The Catalytic Triad:** Always remember the three amino acids involved in serine proteases: **Ser-His-Asp**. * **Serine Protease Inhibitors (SERPINs):** Deficiencies in these lead to clinical conditions (e.g., **α1-Antitrypsin deficiency** leading to emphysema and liver cirrhosis). * **Other Protease Classes:** * **Cysteine Proteases:** Caspases (apoptosis), Cathepsins. * **Aspartyl Proteases:** Pepsin, Renin, HIV Protease. * **Metalloproteases:** Carboxypeptidase, Matrix Metalloproteinases (MMPs), ACE. * **Zymogens:** Most serine proteases are secreted as inactive precursors (e.g., Trypsinogen) to prevent autodigestion of the pancreas.

Question 414: Activation energy is the free energy difference between which of the following?

A. Substrate and product
B. Substrate and transition state (Correct Answer)
C. Transition state and product
D. Sum of all the above

Explanation: **Explanation:** **1. Why Option B is Correct:** In any biochemical reaction, substrates do not convert into products instantaneously. They must first reach a high-energy, unstable intermediate state known as the **Transition State (T‡)**. The **Activation Energy ($E_a$)** is defined as the threshold energy required to lift the substrate from its ground state to this transition state. From a medical biochemistry perspective, **enzymes function by lowering this activation energy**. By stabilizing the transition state, enzymes allow more substrate molecules to cross the energy barrier at body temperature, thereby increasing the reaction rate without altering the overall equilibrium. **2. Why Other Options are Incorrect:** * **Option A (Substrate and Product):** The free energy difference between the substrate and the product is known as **Gibbs Free Energy ($\Delta G$)**. This determines the spontaneity and direction of the reaction, not its speed. * **Option B (Transition state and Product):** This represents the energy released as the unstable intermediate collapses into the final product. It does not define the barrier to starting the reaction. * **Option D:** Activation energy is a specific measurement between two distinct points on an energy profile; it is not a cumulative sum of all energy changes. **3. High-Yield Clinical Pearls for NEET-PG:** * **Enzyme Kinetics:** Enzymes **decrease** activation energy but **do not change** the $\Delta G$ or the equilibrium constant ($K_{eq}$). * **Transition State Analogs:** Drugs that mimic the transition state of a substrate (e.g., **Statins** mimicking the HMG-CoA intermediate) act as potent competitive inhibitors because they bind to the enzyme's active site with higher affinity than the substrate itself. * **Arrhenius Equation:** A higher activation energy results in a slower reaction rate.

Question 415: Which amino acid is responsible for the activation of Thioredoxin reductase?

A. Serine
B. Selenocysteine (Correct Answer)
C. Cysteine
D. Alanine

Explanation: **Explanation:** **Thioredoxin reductase** is a critical flavoprotein enzyme that reduces thioredoxin, a protein essential for DNA synthesis (via ribonucleotide reductase) and the defense against oxidative stress. **Why Selenocysteine is correct:** The catalytic activity of Thioredoxin reductase is dependent on **Selenocysteine (Sec)**, often referred to as the **21st amino acid**. Selenocysteine contains a selenium atom in place of the sulfur found in cysteine. Because selenium has a lower pKa and higher nucleophilicity than sulfur, it allows the enzyme to carry out redox reactions more efficiently at physiological pH. The Selenocysteine residue is located at the C-terminal active site of the enzyme; without it, the enzyme loses its catalytic power. **Why incorrect options are wrong:** * **Cysteine:** While cysteine is structurally similar and involved in disulfide bond formation within the enzyme, it cannot replace the specific redox efficiency provided by the selenium atom in the active site. * **Serine:** Serine contains a hydroxyl group (-OH) which is not redox-active and cannot facilitate the electron transfer required by this enzyme. * **Alanine:** Alanine is a non-polar amino acid with a simple methyl side chain; it lacks the functional groups necessary for catalysis. **Clinical Pearls for NEET-PG:** * **Genetic Coding:** Selenocysteine is encoded by the **UGA stop codon**, requiring a specific mRNA structure called the **SECIS element** (Selenocysteine Insertion Sequence). * **Other Selenoenzymes:** Glutathione peroxidase, Deiodinases (converting T4 to T3), and Selenoprotein P. * **Trace Element:** Selenium deficiency can lead to **Keshan disease** (cardiomyopathy) or **Kashin-Beck disease** (osteoarthropathy).

Question 416: A hepatic enzyme undergoes phosphorylation from a dephosphorylated state. Which of the following is true regarding this process?

A. Affected by the level of catecholamines
B. Occurs in starvation rather than a well-fed state
C. Always activated by cAMP-dependent protein kinase (Correct Answer)
D. Always activates the enzyme

Explanation: **Explanation:** The regulation of hepatic enzymes via covalent modification (phosphorylation/dephosphorylation) is a cornerstone of metabolic control. **1. Why Option C is Correct:** Phosphorylation of enzymes in the liver is primarily mediated by **Protein Kinase A (PKA)**. This kinase is "cAMP-dependent" because it is activated when glucagon or epinephrine binds to G-protein coupled receptors, increasing intracellular cAMP levels. Regardless of whether the phosphorylation leads to activation or inhibition of the specific enzyme, the **process** of adding a phosphate group in this signaling cascade is consistently driven by cAMP-dependent protein kinase. **2. Why Other Options are Incorrect:** * **Option A:** While catecholamines (epinephrine) do influence phosphorylation, they are not the *only* regulators. Glucagon is the primary driver in the liver. The question asks for a definitive truth regarding the "process" of phosphorylation itself. * **Option B:** Phosphorylation occurs in both states, though it is *predominant* during starvation (via glucagon). However, specific enzymes (like those in the kinase cascade) can be phosphorylated in various physiological states. * **Option D:** Phosphorylation is a molecular "switch," but it does not always turn the enzyme "on." For example, phosphorylation **activates** Glycogen Phosphorylase (catabolic) but **inhibits** Glycogen Synthase and Pyruvate Kinase (anabolic). **Clinical Pearls for NEET-PG:** * **Rule of Thumb:** In the liver, phosphorylation generally **activates catabolic** enzymes (breaking down stores) and **inactivates anabolic** enzymes (building stores). * **Exceptions:** In cardiac muscle, phosphorylation of Phosphofructokinase-2 (PFK-2) *activates* glycolysis, whereas in the liver, it *inhibits* it. * **Key Enzyme:** **Protein Phosphatase-1** is the enzyme responsible for the reverse process (dephosphorylation), typically stimulated by **Insulin** in the well-fed state.

Question 417: B-Carotene, the precursor of vitamin A, is oxidatively cleaved by which enzyme?

A. beta-Carotene dioxygenase (Correct Answer)
B. Oxygenase
C. Hydroxylase
D. Transferase

Explanation: **Explanation:** **1. Why the Correct Answer is Right:** $\beta$-Carotene is a provitamin A carotenoid found in plants. The primary step in its conversion to Vitamin A occurs in the intestinal mucosa. The enzyme **$\beta$-Carotene dioxygenase** (specifically $\beta, \beta$-carotene 15,15'-monooxygenase) catalyzes the **oxidative cleavage** of the central double bond of $\beta$-carotene. This reaction requires molecular oxygen and bile salts for emulsification. The cleavage of one molecule of $\beta$-carotene ideally yields **two molecules of Retinal** (Vitamin A aldehyde), which are subsequently reduced to Retinol. **2. Why the Incorrect Options are Wrong:** * **Oxygenase:** This is a broad category of enzymes. While $\beta$-carotene dioxygenase belongs to this class, "Oxygenase" is too non-specific for a competitive exam like NEET-PG when the specific enzyme name is provided. * **Hydroxylase:** These enzymes add a hydroxyl group (-OH) to a substrate. While hydroxylation is involved in the metabolism of Vitamin D or the synthesis of steroid hormones, it is not the mechanism for the central cleavage of $\beta$-carotene. * **Transferase:** These enzymes catalyze the transfer of functional groups (e.g., methyl or phosphate groups) from one molecule to another. They are not involved in the oxidative breakdown of carotenoids. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Site of Conversion:** Primarily the **intestinal mucosa**, but also occurs in the liver and kidneys. * **Efficiency:** The conversion is inefficient; it takes approximately 6 $\mu$g of $\beta$-carotene to produce 1 $\mu$g of Retinol. * **Hypervitaminosis A:** Unlike preformed Vitamin A (Retinol), excessive intake of $\beta$-carotene does not cause Vitamin A toxicity because the cleavage enzyme is regulated; it only causes **Carotenemia** (yellowish skin discoloration, but notably spares the sclera). * **Requirement:** The reaction requires **Iron** as a cofactor.

Question 418: The Rossmann fold-associated NADH domain is a structural motif found in which of the following enzymes?

A. Isocitrate Dehydrogenase (Correct Answer)
B. Pyruvate Dehydrogenase
C. Citrate synthase
D. Succinate Dehydrogenase

Explanation: **Explanation:** The **Rossmann fold** is a classic structural motif found in proteins that bind nucleotides, particularly the cofactor **NAD+ (or NADH)**. It consists of a series of alternating alpha-helices and beta-strands (typically $\beta-\alpha-\beta-\alpha-\beta$ units) that form a stable domain for nucleotide binding. **Why Isocitrate Dehydrogenase (ICD) is Correct:** Isocitrate Dehydrogenase is a key rate-limiting enzyme of the TCA cycle that catalyzes the oxidative decarboxylation of isocitrate to $\alpha$-ketoglutarate. This reaction requires **NAD+** (in the mitochondria) or **NADP+** (in the cytosol) as an electron acceptor. The enzyme utilizes the **Rossmann fold** to specifically bind these nicotinamide adenine dinucleotides. **Analysis of Incorrect Options:** * **Pyruvate Dehydrogenase (PDH):** This is a multi-enzyme complex. While it uses NAD+, its primary structural domains are specialized for its three subunits (E1, E2, E3) and involve lipoamide and TPP binding rather than the classic Rossmann fold for its primary catalytic action. * **Citrate Synthase:** This enzyme does not involve a redox reaction and **does not bind NAD+/NADH**. It catalyzes the condensation of Acetyl-CoA and Oxaloacetate. * **Succinate Dehydrogenase (SDH):** This is unique because it is the only TCA cycle enzyme that uses **FAD** (covalently bound) instead of NAD+. It is also part of Complex II of the Electron Transport Chain. **High-Yield NEET-PG Pearls:** * **Rossmann Fold:** Always associate this with **NAD/NADH binding** domains in dehydrogenases (e.g., Lactate Dehydrogenase, Alcohol Dehydrogenase, Isocitrate Dehydrogenase). * **Rate-Limiting Step:** Isocitrate Dehydrogenase is the primary rate-limiting enzyme of the TCA cycle, inhibited by ATP/NADH and activated by ADP/$\text{Ca}^{2+}$. * **SDH Fact:** Succinate Dehydrogenase is the only TCA enzyme embedded in the inner mitochondrial membrane; all others are in the matrix.

Question 419: What is the definition of enzyme specificity?

A. The amount of enzyme causing the transformation of 1 micromole of substrate per minute under standard conditions. (Correct Answer)
B. The amount of enzyme required per second for the formation of one mole of product.
C. The number of binding sites on an enzyme for a substrate.
D. The ability of an enzyme to bind with various substrates.

Explanation: ### Explanation **Correct Option: A** The question asks for the definition of an **International Unit (IU)** of enzyme activity, which is the standard measure of enzyme potency. One IU is defined as the amount of enzyme that catalyzes the transformation of **1 micromole ($\mu$mol) of substrate per minute** under optimal conditions (standardized pH, temperature, and substrate concentration). This is a fundamental concept in clinical biochemistry used to quantify enzyme levels in a patient's serum. **Analysis of Incorrect Options:** * **Option B:** This describes the **Katal (kat)**. One Katal is the amount of enzyme that transforms one mole of substrate per second. It is the SI unit of enzyme activity, though IU is more commonly used in clinical practice ($1 \text{ kat} = 6 \times 10^7 \text{ IU}$). * **Option C:** This refers to the **valency** or the number of active sites on an enzyme, which relates to its quaternary structure and cooperativity, not its activity units. * **Option D:** This describes **Enzyme Specificity** (e.g., absolute, group, or linkage specificity). The question's phrasing in the prompt suggests a definition of "activity" rather than "specificity," despite the label used in the question stem. **High-Yield Clinical Pearls for NEET-PG:** * **Specific Activity:** Defined as the number of enzyme units per milligram of protein. It is a measure of **enzyme purity**. * **Turnover Number ($K_{cat}$):** The number of substrate molecules converted into product per unit time by a single catalytic site when the enzyme is fully saturated. * **Diagnostic Enzymes:** In clinical settings, we measure the *activity* (IU/L) rather than the *mass* of enzymes (e.g., LDH, CK-MB, ALT) to diagnose organ damage.

Question 420: Which molecule inhibits the conversion of citrate to cis-aconitate?

A. Malonate
B. Fluoride
C. Arsenite
D. Fluoroacetate (Correct Answer)

Explanation: **Explanation:** The conversion of **Citrate to Cis-aconitate** (and subsequently to Isocitrate) is catalyzed by the enzyme **Aconitase** in the TCA cycle. **Why Fluoroacetate is correct:** Fluoroacetate itself is not the inhibitor; it undergoes "lethal synthesis." It reacts with Coenzyme A to form Fluoroacetyl-CoA, which then condenses with oxaloacetate to form **Fluorocitrate**. Fluorocitrate is a potent **suicide inhibitor of Aconitase**. By binding irreversibly to the enzyme, it halts the TCA cycle, leading to a buildup of citrate and a failure of cellular respiration. **Why other options are incorrect:** * **Malonate:** A classic example of a **competitive inhibitor** that inhibits **Succinate Dehydrogenase** (converting succinate to fumarate). * **Fluoride:** Inhibits **Enolase** in the Glycolytic pathway by complexing with magnesium and phosphate. It is used in blood collection tubes (grey top) to prevent glucose breakdown. * **Arsenite:** Inhibits enzymes requiring **Lipoic acid** as a cofactor, specifically the **Pyruvate Dehydrogenase (PDH) complex** and **$\alpha$-ketoglutarate dehydrogenase**. **High-Yield Clinical Pearls for NEET-PG:** * **Suicide Inhibition:** Also known as mechanism-based inhibition (e.g., Allopurinol for Xanthine Oxidase, Aspirin for COX). * **Aconitase** contains an **Iron-Sulfur (Fe-S) cluster** which is essential for its catalytic activity. * **Arsenic Poisoning:** Presents with "garlic breath" and rice-water stools; it inhibits PDH, leading to lactic acidosis.

Practice by Chapter

Enzyme Classification and Nomenclature

Practice Questions

Enzyme Kinetics and Michaelis-Menten Equation

Practice Questions

Enzyme Inhibition: Competitive and Non-competitive

Practice Questions

Allosteric Regulation

Practice Questions

Coenzymes and Cofactors

Practice Questions

Isoenzymes and Clinical Significance

Practice Questions

Enzyme Regulation: Covalent Modification

Practice Questions

Enzyme Regulation: Zymogen Activation

Practice Questions

Enzyme Induction and Repression

Practice Questions

Ribozymes and Catalytic RNA

Practice Questions

Enzyme Diagnostic Applications

Practice Questions

Enzyme Therapy and Inhibitors as Drugs

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Enzymes — MCQs

Enzymes — MCQs

On this page

Practice by Chapter

Want unlimited practice?